How ICMR and Others Spun Covaxin's Phase 1 Trial Results Out of Context

This article has been removed following an ex parte injunction of a court in Telangana, delivered following a petition filed by Bharat Biotech Ltd.

Bharat Biotech has also filed a Rs 100 crore defamation case against The Wire, its editors, and 10 staffers and contributors.

The Wire will be fighting this injunction and defamation plaint.